No Data
No Data
Zhejiang Jianfeng Group Co., Ltd. (SHSE:600668) Investors Are Less Pessimistic Than Expected
Jianfeng Group 2024 Semi-Annual Report
Summary of Jianfeng Group\'s 2024 Semi-Annual Report
Zhejiang Jianfeng Group (600668.SH): net income in the first half of the year was 47.6241 million yuan, a year-on-year decrease of 57.33%.
Zhejiang Jianfeng Group (600668.SH) released its semi-annual report for 2024, with the company achieving revenue of 1.359 billion yuan during the reporting period, a decrease of 1.62% compared to the same period last year; the net income attributable to the shareholders of the listed company was 47.6241 million yuan, a decrease of 57.33% compared to the same period last year; the net income attributable to the shareholders of the listed company, excluding non-recurring gains and losses, was 38.0096 million yuan, a decrease of 62.62% compared to the same period last year; the basic earnings per share was 0.1384 yuan per share.
Zhejiang Jianfeng Group (600668.SH) released its performance for the first half of the year, with a net income of 47.6241 million yuan, a decrease of 57.33% year-on-year.
Zhejiang Jianfeng Group (600668.SH) released its 2024 interim report, with revenue of ...
Zhejiang Jianfeng Group (600668.SH): The supplementary application for pharmaceutical approval of Loratadine Hydrochloride Eye Drops has been approved.
On August 13th, Gelunhui announced that Zhejiang Jianfeng Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Zhejiang Jianfeng Group (600668.SH), received the approval notification of the supplement application for the drug approval document for Olodaterol Hydrochloride Eye Drops issued by the National Medical Products Administration. Olodaterol hydrochloride is a third-generation, potent and safe anti-allergic drug developed by Japan's Hiap Hoe Fermentation Co., Ltd. It was launched in the United States and Japan in 1997 and 2001, respectively. Belgium's Alcon developed it into a 0.1% eye drops under the trade name Patanol, which is used to treat allergic conjunctivitis. Olodaterol hydrochloride has the effect of inhibiting histamine release.
No Data
No Data